<div id="readability-page-1"><p>ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 831,100 shares, a decline of 10.1% from the August 31st total of 924,500 shares. Currently, 3.7% of the company's shares are short sold. Based on an average daily trading volume, of 337,000 shares, the days-to-cover ratio is currently 2.5 days.</p><h2>Wall Street Analysts Forecast Growth</h2><p>A number of research analysts have weighed in on ICUI shares. Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of ICU Medical in a research note on Thursday, August 8th. KeyCorp lifted their price target on shares of ICU Medical from $136.00 to $147.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, August 8th. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, September 12th. Finally, StockNews.com raised shares of ICU Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Thursday, September 12th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, ICU Medical has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $149.00.</p><p><b>Read Our Latest Stock Report on ICUI</b></p><h2>Insider Transactions at ICU Medical</h2><p>In other news, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the business's stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the transaction, the vice president now owns 4,482 shares of the company's stock, valued at approximately $645,901.02. The disclosure for this sale can be found here. Insiders sold a total of 28,552 shares of company stock worth $4,537,802 in the last quarter. 6.70% of the stock is owned by company insiders. </p><h2>Hedge Funds Weigh In On ICU Medical</h2><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Scout Investments Inc. increased its holdings in shares of ICU Medical by 16.3% in the first quarter. Scout Investments Inc. now owns 51,819 shares of the medical instruments supplier's stock valued at $5,463,000 after purchasing an additional 7,272 shares during the last quarter. Wakefield Asset Management LLLP acquired a new position in shares of ICU Medical in the first quarter valued at $989,000. Vanguard Group Inc. increased its holdings in shares of ICU Medical by 14.8% in the fourth quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier's stock valued at $243,438,000 after purchasing an additional 315,103 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in shares of ICU Medical by 52.1% in the first quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock valued at $3,068,000 after purchasing an additional 9,793 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds. </p><h2>ICU Medical Stock Down 0.0 %</h2><p>Shares of ICUI stock traded down $0.01 during trading on Friday, reaching $174.47. The company's stock had a trading volume of 177,791 shares, compared to its average volume of 280,425. The business has a fifty day moving average price of $154.77 and a 200-day moving average price of $124.01. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The company has a market cap of $4.25 billion, a price-to-earnings ratio of -71.21 and a beta of 0.65. ICU Medical has a one year low of $78.28 and a one year high of $181.87. </p><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.56. The business had revenue of $596.50 million for the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. Analysts anticipate that ICU Medical will post 3.76 earnings per share for the current year. </p><h2>About ICU Medical</h2> (Get Free Report)<p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p><h2>Read More</h2><ul><li>Five stocks we like better than ICU Medical</li><li>Election Stocks: How Elections Affect the Stock Market</li><li>Simon Property REIT: A Safe Bet for Growth and Steady Dividends</li><li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li><li>CarMax’s Impressive Rally: What Investors Should Watch Next</li><li>Which Wall Street Analysts are the Most Accurate?</li><li>MarketBeat Week in Review – 9/23 - 9/27</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ NOTICE: You have until Tuesday, November 19th <span><span>(From Behind the Markets)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw"/></p><h2>Should you invest $1,000 in ICU Medical right now?</h2><p>Before you consider ICU Medical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p><p>While ICU Medical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p> </div>

ICUI

<p>ICU Medical, Inc. (NASDAQ:ICUI) experienced a 10.1% decline in short interest in September, with 831,100 shares short sold as of September 15th. This is down from 924,500 shares at the end of August. The short-interest ratio is currently 2.5 days, representing 3.7% of the company's shares. Analysts have mixed ratings, with one hold and four buy ratings, and a consensus rating of "Moderate Buy." Insiders sold a total of 28,552 shares in the last quarter, while institutional investors hold 96.10% of the stock.</p>

Short Interest in ICU Medical, Inc. (NASDAQ:ICUI) Declines By 10.1%